您好,欢迎来到阿仪网! 请登录 免费注册

  • 高级会员服务
  • |
  • 广告位服务
  • |
  • 设为首页
  • |
  • 收藏本站
  • |
  • 诚信档案

    • 会员类型:标准版会员
    • 阿仪网标准版会员:8年
    • 工商认证【已认证】
    • 最后认证时间:无需年检
    • 注册号:**** 【已认证】
    • 法人代表:谭春** 【已认证】
    • 企业类型:经销商 【已认证】
    • 注册资金:人民币万 【已认证】
    • 产品数:

上海雅吉生物科技有限公司 主营产品:免疫组化试剂盒,ELISA试剂盒,抗体,细胞,对照品

第8年

当前位置:阿仪网>上海雅吉生物科技有限公司>技术文章>文献引用产品:人皮肤成纤维细胞HDF-a

企业档案

会员类型:标准版

已获得阿仪网信誉   等级评定
18成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

阿仪网标准版会员:8年

工商认证 【已认证】

最后认证时间:无需年检

注册号:**** 【已认证】

法人代表:谭春** 【已认证】

参观次数:2676310

手机网站:http://wap.app17.com/c141887/

公司网站:http://www.yajimall.com

技术文章

文献引用产品:人皮肤成纤维细胞HDF-a

点击次数:620 发布时间:2026/6/5 8:37:59

文章标题:In Vivo CRISPR Screening Identifies the Glutamate Receptor GRIA2 as Promoting Peritoneal Metastasis of Gastric Cancer via Calcium-Dependent β-Catenin Activation

作者列表:Jie Sun, Xu Yang, Wenchao Jiang, Chengbo Ji, Yingying Wu, Haoyu Sun, Xinyou Liu, Masami Yamamoto, Tetsuya Tsukamoto, Sachiyo Nomura, Junjie Zhao, Yuanyuan Ruan, Haojie Li, Xuefei Wang

影响因子:14.1

期刊:Advanced Science

发表时间:2026-3-10

DOI:10.1002/advs.202521746

文献主题:ABSTRACT

Peritoneal mmbedstasis is the most lethal manifestation of gastric cancer, with a median survival of less than one year, highlighting the need for new therapeutic targets. Through an in vivo genome-wide CRISPR/Cas9 screen, we identified GRIA2, an AMPA-type glutamate receptor subunit, as a key driver of peritoneal mmbedstasis. GRIA2 promotes gastric cancer cell migration, invasion, stemness, and adhesion to mesothelial cells in a glutamate-dependent manner. Mechanistically, glutamate activates GRIA2, enhancing its interaction with GSK-3β and inducing calcium influx, inhibiting GSK-3β kinase activity and stabilizing β-catenin, thereby activating the Wnt/β-catenin signaling pathway. Single-cell RNA sequencing revealed that cancer-associated fibroblasts are the primary source of glutamate in the peritoneal microenvironment, which establishes a paracrine axis that enhances GRIA2-driven mmbedstasis. Pharmacological inhibition of AMPA receptors with NBQX and Selurampanel suppressed peritoneal mmbedstasis in both cell line-derived and patient-derived organoid xenograft (PDOX) mouse models. In clinical analysis, GRIA2 expression in peritoneal mmbedstases correlated with the levels of β-catenin and phosphorylated GSK-3β (serine 9), with high GRIA2 expression predicting poor prognosis. These findings suggest that GRIA2 is a novel therapeutic target, and AMPA receptor antagonists are promising agents for treating gastric cancer peritoneal mmbedstasis.


原创作者:上海雅吉生物科技有限公司

推荐产品

在线咨询5分钟应答

提交